Federal drug prices
Subtitle: effects of opening the pharmaceutical schedule are uncertain : statement of Bernice Steinhardt, Director, Health Services Quality and Public Health Issues, Health, Education, and Human Services Division, before the Subcommittee on Health, Committee on Veterans' Affairs, House of Representatives
By: United States General Accounting Office.
Contributors: United States. General Accounting Office.
Series: Testimony -- GAO/T-HEHS-97-171.
Publisher: The Office; The Office [distributor
Published: 1997
Place of publication: Washington, D.C; Gaithersburg, MD (P.O. Box 6015, Gaithersburg 20884-6015)
Language: eng
Format: Microform
Number of pages: 12
Subjects: United States. -- General Services Administration.; Drugs -- Prices -- United States.; Government purchasing -- United States.
Other titles: Effects of opening the pharmaceutical schedule are uncertain.
Notes: Shipping list no.: 98-0285-M.

"July 10, 1997."

Includes bibliographical references.

Microfiche. [Washington, D.C.] : U.S. General Accounting Office, [1997?] 1 microfiche : negative.